BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brouwer A, Carhart-Harris RL. Pivotal mental states. J Psychopharmacol 2021;35:319-52. [PMID: 33174492 DOI: 10.1177/0269881120959637] [Cited by in Crossref: 10] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Dourron HM, Strauss C, Hendricks PS, Barker E. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis. Pharmacol Rev 2022;74:982-1027. [DOI: 10.1124/pharmrev.121.000514] [Reference Citation Analysis]
2 Rabeyron T. Psychoanalytic psychotherapies and the free energy principle. Front Hum Neurosci 2022;16:929940. [DOI: 10.3389/fnhum.2022.929940] [Reference Citation Analysis]
3 Bhatt SR, Armstrong M, Parker T, Maviglia M, Kass R, Leeman L, Romo P, Ziedonis D. Psychedelic Therapies at the Crossroads of Trauma and Substance Use: Historical Perspectives and Future Directions, Taking a Lead From New Mexico. Front Pharmacol 2022;13:905753. [DOI: 10.3389/fphar.2022.905753] [Reference Citation Analysis]
4 Chirico A, Pizzolante M, Kitson A, Gianotti E, Riecke BE, Gaggioli A. Defining Transformative Experiences: A Conceptual Analysis. Front Psychol 2022;13:790300. [DOI: 10.3389/fpsyg.2022.790300] [Reference Citation Analysis]
5 Kopra EI, Ferris JA, Rucker JJ, Mcclure B, Young AH, Copeland CS, Winstock AR. Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD). J Psychopharmacol. [DOI: 10.1177/02698811221099650] [Reference Citation Analysis]
6 Soares CM, Leite Â, Pinto M. Self-Care Practices with Psychedelics – A Qualitative Study of Users’ Perspectives. Journal of Psychoactive Drugs. [DOI: 10.1080/02791072.2022.2071134] [Reference Citation Analysis]
7 James E, Keppler J, L Robertshaw T, Sessa B. N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine. Hum Psychopharmacol 2022;37:e2835. [PMID: 35175662 DOI: 10.1002/hup.2835] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Mallaroni P, Mason NL, Vinckenbosch FRJ, Ramaekers JG. The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides. Psychopharmacology (Berl) 2022. [PMID: 35487983 DOI: 10.1007/s00213-022-06142-4] [Reference Citation Analysis]
9 Raison CL, Jain R, Penn AD, Cole SP, Jain S. Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States. Front Psychiatry 2022;13:831092. [DOI: 10.3389/fpsyt.2022.831092] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wolff M, Mertens LJ, Walter M, Enge S, Evens R. The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility. J Psychopharmacol 2022;36:387-408. [DOI: 10.1177/02698811211073758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sekula AD, Downey L, Puspanathan P. Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy. Front Psychol 2022;13:813746. [DOI: 10.3389/fpsyg.2022.813746] [Reference Citation Analysis]
12 Peill JM, Trinci KE, Kettner H, Mertens LJ, Roseman L, Timmermann C, Rosas FE, Lyons T, Carhart-Harris RL. Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience. J Psychopharmacol 2022;:2698811211066709. [PMID: 34983255 DOI: 10.1177/02698811211066709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
13 Whitfield HJ. A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development. Front Psychiatry 2021;12:727572. [PMID: 34950063 DOI: 10.3389/fpsyt.2021.727572] [Reference Citation Analysis]
14 Timmermann C, Kettner H, Letheby C, Roseman L, Rosas FE, Carhart-Harris RL. Psychedelics alter metaphysical beliefs. Sci Rep 2021;11:22166. [PMID: 34815421 DOI: 10.1038/s41598-021-01209-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
15 Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC, Alderton KL, Williams TM, Blemings A, Lafrance A, Nicholls DE, Erritzoe D, Nutt DJ, Carhart-Harris RL. Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study". Front Psychiatry 2021;12:735523. [PMID: 34744825 DOI: 10.3389/fpsyt.2021.735523] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Rodríguez Arce JM, Winkelman MJ. Psychedelics, Sociality, and Human Evolution. Front Psychol 2021;12:729425. [PMID: 34659037 DOI: 10.3389/fpsyg.2021.729425] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Verroust V, Zafar R, Spriggs MJ. Psilocybin in the treatment of anorexia nervosa: The English transition of a French 1959 case study. Annales Médico-psychologiques, revue psychiatrique 2021;179:777-81. [DOI: 10.1016/j.amp.2021.08.004] [Reference Citation Analysis]
18 Khan SM, Carter GT, Aggarwal SK, Holland J. Psychedelics for Brain Injury: A Mini-Review. Front Neurol 2021;12:685085. [PMID: 34393973 DOI: 10.3389/fneur.2021.685085] [Reference Citation Analysis]
19 Kočárová R, Horáček J, Carhart-Harris R. Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential? Front Psychiatry 2021;12:661233. [PMID: 34349678 DOI: 10.3389/fpsyt.2021.661233] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
20 Martial C, Fontaine G, Gosseries O, Carhart-Harris R, Timmermann C, Laureys S, Cassol H. Losing the Self in Near-Death Experiences: The Experience of Ego-Dissolution. Brain Sci 2021;11:929. [PMID: 34356163 DOI: 10.3390/brainsci11070929] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Jerath R, Beveridge C. Harnessing the Spatial Foundation of Mind in Breaking Vicious Cycles in Anxiety, Insomnia, and Depression: The Future of Virtual Reality Therapy Applications. Front Psychiatry 2021;12:645289. [PMID: 34305666 DOI: 10.3389/fpsyt.2021.645289] [Reference Citation Analysis]
22 Papp M, Cubala WJ, Swiecicki L, Newman-Tancredi A, Willner P. Perspectives for therapy of treatment-resistant depression. Br J Pharmacol 2021. [PMID: 34128229 DOI: 10.1111/bph.15596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Rucker JJ, Seth P. Psychedelics: Old drugs, new trips. J Psychopharmacol 2021;35:316-8. [PMID: 33853423 DOI: 10.1177/02698811211003495] [Reference Citation Analysis]
24 Aday JS, Davis AK, Mitzkovitz CM, Bloesch EK, Davoli CC. Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects. ACS Pharmacol Transl Sci 2021;4:424-35. [PMID: 33860172 DOI: 10.1021/acsptsci.1c00014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]